 |
인쇄하기
취소
|
Shinpoong wins trademark lawsuit against Novartis Korea
Shinpoong Pharmaceutical has won the right to market a medication for hypertension in the trade name of Divaltan
The company announced Wednesday that it secured the right to use such trademark on Korean market after a patent court ruled in favor of Shinpoong.
Shinpoong registered Divaltan on September 2, 2008, but failed to use the trademark for three consecutive years, Then, Novartis Ko...
The company announced Wednesday that it secured the right to use such trademark on Korean market after a patent court ruled in favor of Shinpoong.
Shinpoong registered Divaltan on September 2, 2008, but failed to use the trademark for three consecutive years, Then, Novartis Ko...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.